I am pleased to share my professional biography, which reflects more than 30 years of experience in pharmaceutical research, translational medicine, drug discovery, clinical development, and strategic leadership. Throughout my career, I have had the opportunity to contribute to the development of innovative therapies, lead global cross-functional teams, and help advance medicines that improve patient outcomes across multiple therapeutic areas. As I continue serving the life sciences industry through advisory and board opportunities, I look forward to applying this experience to help organizations accelerate innovation and create meaningful impact.

Matthew Smollin, PharmD, is an accomplished leader in medical affairs and clinical innovation with over 15 years of clinical experience and a decade of industry expertise spanning clinical research, regulatory strategy, and team leadership. As Vice President of Medical Affairs at Karius, Inc., he directs medical and scientific strategies, guiding breakthrough advancements in molecular diagnostics while navigating complex FDA and Medicare regulatory processes. Throughout his career, he has successfully built and managed high-performing teams, fostered strong relationships with key opinion leaders, and played a pivotal role in clinical trial design, publication strategy, and scientific engagement. A respected speaker and thought leader, Dr. Smollin’s expertise in infectious disease diagnostics and next-generation sequencing has shaped industry best practices and advanced clinical innovation. His dedication to scientific excellence, strategic vision, and ability to translate complex medical insights into impactful solutions make him a driving force in the evolution of precision medicine and diagnostic technologies.